Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-12-22T08:15:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.6%
    Check dated 2024-12-15T00:39:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T22:37:00.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-11-30T17:09:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study has posted results for a Phase 1/2 trial evaluating the safety and anti-tumor activity of galinpepimut-S in combination with pembrolizumab in patients with advanced cancers, including metastatic colorectal cancer and triple-negative breast cancer, with a focus on various treatment phases and patient response metrics.
    Difference
    69%
    Check dated 2024-11-23T06:18:44.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-11-16T02:02:34.000Z thumbnail image

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.